Effect of Arjun Chāl on cardiovascular risk factors - a randomized controlled clinical trial.

Saima SaleemAbdul Haseeb AnsariAysha Ansari

Published in: Journal of complementary & integrative medicine (2021)

Both test and control drugs were effective, but Arjun Chāl had a slight edge over amlodipne and atorvastatin, and was found to be safe and well tolerated. It has a cardio protective potential and hence effective to delay/prevent CVD in patient with cardiovascular risk factor.Keywords: Unani System of Medicine; T. arjuna; Arjun Chāl; Efficacy; Safety; Cardiovascular risk factor.

Keyphrases

cardiovascular risk factors
risk factors
room temperature
cardiovascular disease
metabolic syndrome
case report
type diabetes
climate change